These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34744456)

  • 41. Human Zwint-1 specifies localization of Zeste White 10 to kinetochores and is essential for mitotic checkpoint signaling.
    Wang H; Hu X; Ding X; Dou Z; Yang Z; Shaw AW; Teng M; Cleveland DW; Goldberg ML; Niu L; Yao X
    J Biol Chem; 2004 Dec; 279(52):54590-8. PubMed ID: 15485811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Jiang J; Liu B; Liu R; Yang W
    Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
    Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
    PeerJ; 2021; 9():e11342. PubMed ID: 33987018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpressed SNRPB/D1/D3/E/F/G correlate with poor survival and immune infiltration in hepatocellular carcinoma.
    Li FP; Liu GH; Zhang XQ; Kong WJ; Mei J; Wang M; Dai YH
    Am J Transl Res; 2022; 14(6):4207-4228. PubMed ID: 35836882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma.
    Yang H; Gao S; Chen J; Lou W
    Cancer Cell Int; 2020; 20():234. PubMed ID: 32536822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma.
    Shang BB; Chen J; Wang ZG; Liu H
    PeerJ; 2021; 9():e12315. PubMed ID: 34754620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD276 Promotes an Inhibitory Tumor Microenvironment in Hepatocellular Carcinoma and is Associated with Poor Prognosis.
    Liu WF; Jiang QY; Qi ZR; Zhang F; Tang WQ; Wang HQ; Dong L
    J Hepatocell Carcinoma; 2024; 11():1357-1373. PubMed ID: 39011124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma.
    Yang M; Qiu Y; Yang Y; Wang W
    Front Cell Dev Biol; 2022; 10():840010. PubMed ID: 35252202
    [No Abstract]   [Full Text] [Related]  

  • 53. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma.
    Liu J; Li W; Zhang J; Ma Z; Wu X; Tang L
    PeerJ; 2019; 7():e8021. PubMed ID: 31695969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.
    Liu ZK; Zhang RY; Yong YL; Zhang ZY; Li C; Chen ZN; Bian H
    PeerJ; 2019; 7():e7436. PubMed ID: 31410310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ZW10 Binding Factor (ZWINT), a Direct Target of Mir-204, Predicts Poor Survival and Promotes Proliferation in Breast Cancer.
    Zhou G; Shen M; Zhang Z
    Med Sci Monit; 2020 Apr; 26():e921659. PubMed ID: 32248204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma.
    Lin T; Lin Z; Mai P; Zhang E; Peng L
    Aging (Albany NY); 2021 Apr; 13(8):11786-11807. PubMed ID: 33878734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on the expression of TOP2A in hepatocellular carcinoma and its relationship with patient prognosis.
    Meng J; Wei Y; Deng Q; Li L; Li X
    Cancer Cell Int; 2022 Jan; 22(1):29. PubMed ID: 35033076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
    Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.